Silence Therapeutics Plc ADR (SLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -46,277 | N/A | N/A | N/A |
| Depreciation Amortization | 637 | N/A | N/A | N/A |
| Accounts receivable | -37,624 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,673 | N/A | N/A | N/A |
| Other Working Capital | 23,956 | N/A | N/A | N/A |
| Other Operating Activity | 43,799 | 0 | 0 | 0 |
| Operating Cash Flow | $-13,836 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -652 | N/A | N/A | N/A |
| Purchase Of Investment | 12,840 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -4 | N/A | N/A | N/A |
| Other Investing Activity | 162 | 0 | 0 | 0 |
| Investing Cash Flow | $12,350 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 20,326 | N/A | N/A | N/A |
| Other Financing Activity | -516 | 0 | 0 | 0 |
| Financing Cash Flow | $19,810 | $N/A | $N/A | $N/A |
| Exchange Rate Effect | -431 | N/A | N/A | N/A |
| Beginning Cash Position | 17,353 | N/A | N/A | N/A |
| End Cash Position | 35,245 | N/A | N/A | N/A |
| Net Cash Flow | $17,891 | $N/A | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -13,836 | N/A | N/A | N/A |
| Capital Expenditure | -656 | N/A | N/A | N/A |
| Free Cash Flow | -14,493 | 0 | 0 | 0 |